Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Charming Medical's revenue for the
six
months ended in Sep. 2025 was $2.16 Mil.
Its revenue for the trailing twelve months (TTM) ended in Sep. 2025 was $5.42 Mil.
Charming Medical's Revenue per Share for the
six
months ended in Sep. 2025 was $0.13.
Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $0.32.
Warning Sign:
Charming Medical Ltd revenue per share is in decline over the past 12 months.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Charming Medical Revenue Related Terms
Charming Medical Revenue Historical Data
* Premium members only.
The historical data trend for Charming Medical's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Charming Medical's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charming Medical Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Charming Medical's Revenue distribution charts can be found below:
* The bar in red indicates where Charming Medical's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $5.42 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charming Medical (MCTA) has a Revenue of $5.42 Mil as of Sep. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Charming Medical and its competitors.
Is Charming Medical's Revenue too high?
Charming Medical's current Revenue is $5.42 Mil. Overall, Charming Medical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Charming Medical's Revenue compare to EHAB and CYH?
Charming Medical's Revenue of $5.42 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Charming Medical and its competitors. Charming Medical's current Revenue is $5.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charming Medical stock overvalued right now?
Charming Medical (MCTA) has a current Revenue of $5.42 Mil. The current Revenue is $5.42 Mil. Charming Medical's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Charming Medical (MCTA), the current Revenue is $5.42 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Address2-20 Paterson Street, Causeway Bay, Units 1803-1806, 18th Floor, Hang Lung Centre, Hong Kong, HKG
Charming Medical Ltd is a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products. It offers a wide range of beauty, wellness, and postpartum services and products rooted and influenced by the principles and practices of TCM, such as the use of herbal ingredients, acupuncture techniques, Tuina massage, and dietary guidance. Its beauty, wellness, and postpartum services include but are not limited to womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, TCM-inspired prenatal massage, and Indonesian traditional abdominal binding.
29GF Score
Get the complete analysis for MCTA
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MCTA has been successfully added to your 
